National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Letermovir for the prophylaxis of cytomegalovirus (CMV) reactivation or disease in adult CMV-seropositive recipients [R+] of an allogeneic haematopoietic stem cell transplant (HSCT).

NCPE Assessment Process Complete
Rapid review commissioned 12/03/2018
Rapid review completed 10/05/2018
Rapid Review outcome A Full pharmacoeconomic assessment is recommended
HTA commissioned by the HSE 29/05/2018
Pre-submission consultation with Applicant 09/07/2018
Submission received from Applicant 02/04/2019
Current Status HTA submission received